The clinical research front has been expanding eastward for the past few years. And there has been a lot of noise about it, with opinions oscillating between overt optimism and concern. We're here to give you frank, first-hand advice on the latest risks and rewards of conducting clinical trials in this region.
Our local team leaders in Australia, China and India answer your questions about regional variation in regulations and patient populations. See their checklist for choosing the right Asia/Pacific partner CRO and insights on each region's future ambitions.
Navigating new global regions, regulatory environments and local population nuances can be daunting for any sponsor. Hear how INC Research helped three different pharmaceutical companies explore Australia, China and India and conduct successful clinical studies there.